Meijer GA "Citations that count, an editorial address to the ISCO membership " Cellular Oncology 26(5-6), 2004. P.353-354, IOS Press, Amsterdam

Eugene Garfield garfield at CODEX.CIS.UPENN.EDU
Fri Mar 25 16:50:14 EST 2005


E-Mail:
Gerrit A. Meijer : ga.meijer at VUmc.nl

TITLE : Citations that count, an editorial address to the ISCO membership
(Editorial Material)

AUTHOR: Meijer, GA

SOURCE: Cellular Oncology 26(5-6), 2004. P.353-354, IOS Press, Amsterdam

ABSTRACT:
Publications in biomedical science follow a vicious circle.  The better the
papers that are published in a journal, the more they are cited, the higher
the impact factor of that journal will be, and thus the more attractive it
is for authors of good papers to submit their manuscripts to that journal.
Many members of ISCO are facing situations where impact factors of journals
in which they publish have a major influence on their chances of
successfully applying for research grants.  In fact, this means that many of
us not automatically will submit their manuscripts to a journal with an
impact factor of 1.2, like Cellular Oncology.  Despite this, the editor,
associate editors and editorial board of Cellular Oncology have accepted the
challenge to position Cellular Oncology as an attractive platform for
publishing scientific communications in the field of oncology.  With the
present issue we feel that we certainly have succeeded, and we want to
stimulate you to help us succeed in the future as well.  One way of doing
this is by showing the ISCO members that Cellular Oncology papers, and in
the past Analytical Cellular Pathology Papers have a potential of being
cited quite well.  To this end we here provide you with an overview of the
most-cited papers of the last five years, stratified by year.  This proves
that publishing in Cellular Oncology, which is listed in Medline, certainly
is an excellent option to reach a large readership.


Publisher: IOS PRESS, NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
IDS Number: 893KF
ISSN: 1570-5870

CITED REFERENCES:
CR ALAIYA A, 2000, ANAL CELL PATHOL, V21, P1
   AUBELE M, 1999, ANAL CELL PATHOL, V19, P53
   AUBELE M, 2002, ANAL CELL PATHOL, V24, P77
   BEST CJM, 2000, ANAL CELL PATHOL, V20, P1
   DELLAMEA V, 2000, ANAL CELL PATHOL, V20, P33
   GAO TY, 1999, ANAL CELL PATHOL, V18, P87
   GERSTNER AOH, 2003, ANAL CELL PATHOL, V25, P51
   GROTE HJ, 2003, ANAL CELL PATHOL, V25, P83
   HAROSKE G, 2001, ANAL CELL PATHOL, V23, P89
   HEINTZMANN R, 2000, ANAL CELL PATHOL, V20, P7
   HEISKANEN M, 2001, ANAL CELL PATHOL, V22, P229
   ILLGES H, 1999, ANAL CELL PATHOL, V19, P99
   LEITE M, 1999, ANAL CELL PATHOL, V19, P139
   LENANDER C, 2001, ANAL CELL PATHOL, V22, P201
   MATTFELDT T, 2002, ANAL CELL PATHOL, V24, P167
   MOTHERBY H, 2002, ANAL CELL PATHOL, V24, P5
   NIELSEN B, 1999, ANAL CELL PATHOL, V19, P21
   PETERSEN I, 2001, ANAL CELL PATHOL, V22, P111
   REMMERBACH TW, 2001, ANAL CELL PATHOL, V22, P211
   REMMERBACH TW, 2003, ANAL CELL PATHOL, V25, P139
   REMMERBACH TW, 2003, ANAL CELL PATHOL, V25, P159
   RODENACKER K, 2003, ANAL CELL PATHOL, V25, P1
   SMOLLE J, 2002, ANAL CELL PATHOL, V24, P59
   TUCCARI G, 1999, ANAL CELL PATHOL, V19, P163
   WAHLBY C, 2002, ANAL CELL PATHOL, V24, P101
   WANG NN, 2000, ANAL CELL PATHOL, V20, P49
   WANG NN, 2001, ANAL CELL PATHOL, V23, P11



More information about the SIGMETRICS mailing list